Egypt Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018

Date: September 25, 2012
Pages: 66
Price:
US$ 2,500.00
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: E91C678741BEN
Leaflet:

Download PDF Leaflet

Egypt Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018
Egypt Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018

Summary

Global Markets Direct’s new report, ”Egypt Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018”, provides key market data on the Egypt Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct’s team of industry experts.

Scope
  • Market size and company share data for Diabetes Care Devices market categories – Glucose Monitoring and Insulin Delivery.
  • Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
  • 2011 company shares and distribution shares data for each of the two market categories.
  • Global corporate-level profiles of key companies operating within the Egypt Diabetes Care Devicesmarket.
  • Key players covered include F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Abbott Laboratories, Bayer HealthCare AG, LifeScan, Inc., Novo Nordisk A/S and others.
Reasons to buy
  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the Egypt Diabetes Care Devices competitive landscape.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
1 TABLE OF CONTENTS

1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 What is This Report About?

3 DIABETES CARE DEVICES IN EGYPT

3.1 Diabetes Care Devices, Egypt, Overall Revenue ($m), USD Constant, 2004-2018
3.2 Diabetes Care Devices, Egypt, Company Share (2010-2011)

4 GLUCOSE MONITORING IN EGYPT

4.1 Glucose Monitoring Overall Revenue, (2004-2018)
  4.1.1 Blood Glucose Meters, Revenue (2004-2018)
4.2 Glucose Monitoring Overall Volume (2004-2018)
  4.2.1 Blood Glucose Meters, Volume (2004-2018)
4.3 Glucose Monitoring Average Price (2004-2018)
4.4 Glucose Monitoring Distribution Share (2010-2011)
4.5 Glucose Monitoring, Egypt, Company Share (2010-2011)

5 INSULIN DELIVERY IN EGYPT

5.1 Insulin Delivery Overall Revenue, (2004-2018)
  5.1.1 Insulin Pens, Revenue (2004-2018)
  5.1.2 Insulin Pumps, Revenue (2004-2018)
5.2 Insulin Delivery Overall Volume (2004-2018)
  5.2.1 Insulin Pens, Volume (2004-2018)
  5.2.2 Insulin Pumps, Volume (2004-2018)
5.3 Insulin Delivery Average Price (2004-2018)
5.4 Insulin Delivery Distribution Share (2010-2011)
5.5 Insulin Delivery, Egypt, Company Share (2010-2011)

6 OVERVIEW OF KEY COMPANIES IN EGYPT DIABETES CARE DEVICES MARKET

6.1 F. Hoffmann-La Roche Ltd.
  6.1.1 Company Overview
6.2 Becton, Dickinson and Company
  6.2.1 Company Overview
6.3 Abbott Laboratories
  6.3.1 Company Overview
6.4 Bayer HealthCare AG
  6.4.1 Company Overview
6.5 LifeScan, Inc.
  6.5.1 Company Overview
6.6 Novo Nordisk A/S
  6.6.1 Company Overview
6.7 Eli Lilly and Company
  6.7.1 Company Overview
6.8 Sanofi
  6.8.1 Company Overview
6.9 ARKRAY, Inc.
  6.9.1 Company Overview
6.10 BIONIME Corporation
  6.10.1 Company Overview
6.11 Terumo Corporation
  6.11.1 Company Overview
6.12 Nipro Corporation
  6.12.1 Company Overview

7 APPENDIX

7.1 Global Markets Direct Research Methodology
7.2 Definitions of Markets Covered in the Report
  7.2.1 Diabetes Care Devices
7.3 Secondary Research
7.4 Primary Research
7.5 Models
7.6 Forecasts
7.7 Expert Panel Validation
7.8 Currency Conversion
7.9 Contact Us
7.10 Disclaimer

LIST OF TABLES

Table 1: Diabetes Care Devices, Egypt, Overall Revenue ($m), USD Constant, 2004-2018
Table 2: Diabetes Care Devices, Egypt, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 3: Diabetes Care Devices, Egypt, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 4: Diabetes Care Devices, Egypt, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 5: Glucose Monitoring, Egypt, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 6: Glucose Monitoring, Egypt, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 7: Blood Glucose Meters (Traditional Glucose Meters), Egypt, Revenue ($m) USD Constant, Historic, 2004-2011
Table 8: Blood Glucose Meters (Traditional Glucose Meters), Egypt, Revenue ($m) USD Constant, Forecast, 2011-2018
Table 9: Glucose Monitoring, Egypt, Volume (Units) by Segment, Historic, 2004-2011
Table 10: Glucose Monitoring, Egypt, Volume (Units) by Segment, Forecast, 2011-2018
Table 11: Blood Glucose Meters (Traditional Glucose Meters), Egypt, Volume (Units), Historic, 2004-2011
Table 12: Blood Glucose Meters (Traditional Glucose Meters), Egypt, Volume (Units), Forecast, 2011-2018
Table 13: Glucose Monitoring, Egypt, Average Price ($), Historic, 2004-2011
Table 14: Glucose Monitoring, Egypt, Average Price ($), Forecast, 2011-2018
Table 15: Glucose Monitoring, Egypt, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 16: Glucose Monitoring, Egypt, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 17: Insulin Delivery, Egypt, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 18: Insulin Delivery, Egypt, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 19: Insulin Pens, Egypt, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 20: Insulin Pens, Egypt, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 21: Insulin Pumps (Traditional Insulin Pumps), Egypt, Revenue ($m) USD Constant, Historic, 2004-2011
Table 22: Insulin Pumps (Traditional Insulin Pumps), Egypt, Revenue ($m) USD Constant, Forecast, 2011-2018
Table 23: Insulin Delivery, Egypt, Volume (Units) by Segment, Historic, 2004-2011
Table 24: Insulin Delivery, Egypt, Volume (Units) by Segment, Forecast, 2011-2018
Table 25: Insulin Pens, Egypt, Volume (Units) by Sub-Segment, Historic, 2004-2011
Table 26: Insulin Pens, Egypt, Volume (Units) by Sub-Segment, Forecast, 2011-2018
Table 27: Insulin Pumps (Traditional Insulin Pumps), Egypt, Volume (Units), Historic, 2004-2011
Table 28: Insulin Pumps (Traditional Insulin Pumps), Egypt, Volume (Units), Forecast, 2011-2018
Table 29: Insulin Delivery, Egypt, Average Price ($), Historic, 2004-2011
Table 30: Insulin Delivery, Egypt, Average Price ($), Forecast, 2011-2018
Table 31: Insulin Delivery, Egypt, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 32: Insulin Delivery, Egypt, Company Share by Revenue ($m), USD Constant, 2010-2011

LIST OF FIGURES

Figure 1: Diabetes Care Devices, Egypt, Overall Revenue ($m), USD Constant, 2004-2018
Figure 2: Diabetes Care Devices, Egypt, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 3: Diabetes Care Devices, Egypt, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 4: Diabetes Care Devices, Egypt, Company Share (%), 2011
Figure 5: Glucose Monitoring, Egypt, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 6: Glucose Monitoring, Egypt, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 7: Blood Glucose Meters (Traditional Glucose Meters), Egypt, Revenue ($m) USD Constant, Historic, 2004-2011
Figure 8: Blood Glucose Meters (Traditional Glucose Meters), Egypt, Revenue ($m) USD Constant, Forecast, 2011-2018
Figure 9: Glucose Monitoring, Egypt, Volume (Units) by Segment, Historic, 2004-2011
Figure 10: Glucose Monitoring, Egypt, Volume (Units) by Segment, Forecast, 2011-2018
Figure 11: Blood Glucose Meters (Traditional Glucose Meters), Egypt, Volume (Units), Historic, 2004-2011
Figure 12: Blood Glucose Meters (Traditional Glucose Meters), Egypt, Volume (Units), Forecast, 2011-2018
Figure 13: Glucose Monitoring, Egypt, Company Share (%), 2011
Figure 14: Insulin Delivery, Egypt, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 15: Insulin Delivery, Egypt, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 16: Insulin Pens, Egypt, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 17: Insulin Pens, Egypt, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 18: Insulin Pumps (Traditional Insulin Pumps), Egypt, Revenue ($m) USD Constant, Historic, 2004-2011
Figure 19: Insulin Pumps (Traditional Insulin Pumps), Egypt, Revenue ($m) USD Constant, Forecast, 2011-2018
Figure 20: Insulin Delivery, Egypt, Volume (Units) by Segment, Historic, 2004-2011
Figure 21: Insulin Delivery, Egypt, Volume (Units) by Segment, Forecast, 2011-2018
Figure 22: Insulin Pens, Egypt, Volume (Units) by Sub-Segment, Historic, 2004-2011
Figure 23: Insulin Pens, Egypt, Volume (Units) by Sub-Segment, Forecast, 2011-2018
Figure 24: Insulin Pumps (Traditional Insulin Pumps), Egypt, Volume (Units), Historic, 2004-2011
Figure 25: Insulin Pumps (Traditional Insulin Pumps), Egypt, Volume (Units), Forecast, 2011-2018
Figure 26: Insulin Delivery, Egypt, Company Share (%), 2011
Figure 27: Global Markets Direct Methodology

COMPANIES MENTIONED

F. Hoffmann-La Roche Ltd.
Becton, Dickinson and Company
Abbott Laboratories
Bayer HealthCare AG
LifeScan, Inc.
Novo Nordisk A/S
Eli Lilly and Company
Sanofi
ARKRAY, Inc.
BIONIME Corporation
Terumo Corporation
Nipro Corporation

Ask Your Question

Egypt Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: